<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<!DOCTYPE GmsArticle SYSTEM "http://www.egms.de/dtd/2.0.34/GmsArticle.dtd">
<GmsArticle xmlns:xlink="http://www.w3.org/1999/xlink">
  <MetaData>
    <Identifier>dgkh000683</Identifier>
    <IdentifierDoi>10.3205/dgkh000683</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-dgkh0006837</IdentifierUrn>
    <ArticleType>Research Article</ArticleType>
    <TitleGroup>
      <Title language="en">Oak-fruit-extract-mediated synthesis of silver and copper quantum dots reduces biofilm gene expression in clinical isolates of Staphylococcus aureus and Acinetobacter baumannii</Title>
      <TitleTranslated language="de">Synthese von Silber- und Kupfer-Quantenpunkten mit Eichelextrakt reduziert die Biofilm-Genexpression in klinischen Isolaten von Staphylococcus aureus und Acinetobacter baumannii</TitleTranslated>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Nabipour</Lastname>
          <LastnameHeading>Nabipour</LastnameHeading>
          <Firstname>Yasman Sadat</Firstname>
          <Initials>YS</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Hesampour</Lastname>
          <LastnameHeading>Hesampour</LastnameHeading>
          <Firstname>Ardeshir</Firstname>
          <Initials>YS</Initials>
          <AcademicTitleSuffix>PhD</AcademicTitleSuffix>
        </PersonNames>
        <Address>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran, phone: &#43;98 2144600200<Affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran</Affiliation></Address>
        <Email>ardeshir.hesampour&#64;iau.ac.i</Email>
        <Creatorrole corresponding="yes" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Asbchin</Lastname>
          <LastnameHeading>Asbchin</LastnameHeading>
          <Firstname>Salman Ahmady</Firstname>
          <Initials>SA</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Microbiology, Faculty of science, University of Mazandaran, Babolsar, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Tajabadi</Lastname>
          <LastnameHeading>Tajabadi</LastnameHeading>
          <Firstname>Maryam</Firstname>
          <Initials>M</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Biology, CT.C., Islamic Azad University, Tehran, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Rostamzad</Lastname>
          <LastnameHeading>Rostamzad</LastnameHeading>
          <Firstname>Arman</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Department of Biology, Faculty of science, Ilam University, Ilam, Iran</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">biofilm inhibition</Keyword>
      <Keyword language="en">Staphylococcus aureus</Keyword>
      <Keyword language="en">Acinetobacter baumannii</Keyword>
      <Keyword language="en">quantum dots</Keyword>
      <Keyword language="en">green synthesis</Keyword>
      <Keyword language="de">Biofilmhemmung</Keyword>
      <Keyword language="de">Staphylococcus aureus</Keyword>
      <Keyword language="de">Acinetobacter baumannii</Keyword>
      <Keyword language="de">Quantenpunkte</Keyword>
      <Keyword language="de">gr&#252;ne Synthese</Keyword>
    </SubjectGroup>
    <DatePublishedList>
      <DatePublished>20261023</DatePublished>
    </DatePublishedList>
    <Language>engl</Language>
    <License license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
      <AltText language="en">This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.</AltText>
      <AltText language="de">Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).</AltText>
    </License>
    <SourceGroup>
      <Journal>
        <ISSN>2196-5226</ISSN>
        <Volume>21</Volume>
        <JournalTitle>GMS Hygiene and Infection Control</JournalTitle>
        <JournalTitleAbbr>GMS Hyg Infect Control</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>74</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="de" linked="yes"><Pgraph><Mark1>Hintergrund:</Mark1> Die Zunahme multiresistenter (MDR) Bakterien, insbesondere <Mark2>Staphylococcus (S.) aureus</Mark2> und <Mark2>Acinetobacter (A.) baumannii</Mark2>, stellt aufgrund ihrer ausgepr&#228;gten F&#228;higkeit zur Biofilmbildung eine globale Herausforderung f&#252;r die Gesundheit dar. Es besteht dringender Bedarf an alternativen Strategien zur Bek&#228;mpfung der Biofilmbildung.</Pgraph><Pgraph><Mark1>Methoden:</Mark1> Silber- (Ag) und Kupfer-Quantenpunkte (Cu-QDs) wurden mittels eines gr&#252;nen hydrothermalen Verfahrens unter Verwendung von Eichelextrakt synthetisiert. Ihre antimikrobielle und biofilmhemmende Aktivit&#228;t wurde gegen stark biofilmproduzierende klinische Isolate von <Mark2>S. aureus</Mark2> (n&#61;5) und <Mark2>A. baumannii</Mark2> (n&#61;5) mittels Mikrodilutionsverfahren und Biofilmhemm-Assays getestet. Der Effekt subinhibitorischer Hemmkonzentrationen (sub-MHK) der QDs auf Biofilm-assoziierte Gene (icaA, icaD, icaR bei <Mark2>S. aureus</Mark2>; bap, ompA bei <Mark2>A. baumannii</Mark2>) wurde mittels RT-qPCR untersucht.</Pgraph><Pgraph><Mark1>Ergebnisse:</Mark1> Die MHK-Werte f&#252;r Ag-QDs und Cu-QDs lagen bei 300 &#181;g&#47;ml bzw. 400 &#181;g&#47;ml. Beide QDs hemmten die Biofilmbildung bei sub-MHK-Konzentrationen signifikant. Die RT-qPCR-Analyse zeigte eine signifikante Herunterregulierung aller getesteten Gene nach QD-Behandlung, wobei Ag-QDs einen st&#228;rkeren inhibitorischen Effekt als Cu-QDs aufwiesen.</Pgraph><Pgraph><Mark1>Schlussfolgerung:</Mark1> Gr&#252;n-synthetisierte Ag-QDs und Cu-QDs zeigen eine signifikante biofilmhemmende Aktivit&#228;t durch die Unterdr&#252;ckung wichtiger Biofilm-assoziierter Gene in <Mark2>S. aureus</Mark2> und <Mark2>A. baumannii</Mark2>. Die Ergebnisse unterstreichen ihr Potenzial als umweltfreundliche, biofilmhemmende Nanowirkstoffe zur Infektionskontrolle.</Pgraph></Abstract>
    <Abstract language="en" linked="yes"><Pgraph><Mark1>Background:</Mark1> The emergence of multidrug-resistant (MDR) bacteria, particularly <Mark2>Staphylococcus (S.) aureus</Mark2> and <Mark2>Acinetobacter (A.) baumannii</Mark2>, poses a critical global health challenge due to their strong ability to form biofilms. Alternative strategies targeting biofilm formation are urgently needed.</Pgraph><Pgraph><Mark1>Methods:</Mark1> Silver (Ag) and copper (Cu) quantum dots (QDs) were synthesized via a green hydrothermal method using oak fruit extract. Their antimicrobial and antibiofilm activities were tested against strong biofilm-producing clinical isolates of <Mark2>S. aureus</Mark2> (n&#61;5) and <Mark2>A. baumannii</Mark2> (n&#61;5) using broth microdilution and biofilm inhibition assays. The effect of sub-MIC concentrations of QDs on biofilm-associated genes (<Mark2>icaA, icaD, icaR</Mark2> in <Mark2>S. aureus</Mark2>; <Mark2>bap, ompA</Mark2> in <Mark2>A. baumannii</Mark2>) was evaluated by RT-qPCR.</Pgraph><Pgraph><Mark1>Results:</Mark1> The MIC values of Ag-QDs and Cu-QDs were 300 &#181;g&#47;mL and 400 &#181;g&#47;mL, respectively. Both QDs significantly inhibited biofilm formation at sub-MIC levels. RT-qPCR analysis showed marked downregulation of all tested genes following QD treatment, with Ag-QDs exhibiting a stronger inhibitory effect than Cu-QDs.</Pgraph><Pgraph><Mark1>Conclusion:</Mark1> Green-synthesized Ag-QDs and Cu-QDs demonstrate significant antibiofilm activity by suppressing key biofilm-related genes in <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2>. These findings highlight their potential as eco-friendly nano-antibiofilm agents for infection control.</Pgraph></Abstract>
    <TextBlock name="Introduction" linked="yes">
      <MainHeadline>Introduction</MainHeadline><Pgraph>The escalating crisis of bacterial antibiotic resistance represents a significant threat to global public health, necessitating the urgent development of novel therapeutic strategies <TextLink reference="1"></TextLink>, <TextLink reference="2"></TextLink>. Among the mechanisms contributing to this resistance, biofilm formation is particularly important, as it confers enhanced protection against antimicrobial agents and host immune responses, rendering infections difficult to eradicate and increasing the risk of healthcare-associated infections (HAIs) <TextLink reference="3"></TextLink>. Quantum dots (QDs), as innovative nanomaterials, have emerged as promising tools in this context due to their intrinsic antimicrobial properties, structural stability, and distinct modes of action that may reduce the likelihood of resistance development <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>.</Pgraph><Pgraph>QDs are multifunctional materials that have shown remarkable potential in biomedical applications, especially in targeting pathogenic biofilms <TextLink reference="6"></TextLink>. Their antimicrobial activity involves multiple mechanisms, including physical disruption of cell membranes, generation of reactive oxygen species (ROS), and, in certain cases, photothermal or photodynamic effects <TextLink reference="7"></TextLink>. These mechanisms allow QDs to inhibit a wide spectrum of bacterial species at lower concentrations than many conventional antibiotics, highlighting their potential as alternative or adjunctive therapeutics in infection control <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink>.</Pgraph><Pgraph><Mark2>Staphylococcus (S.) aureus</Mark2>, classified by the World Health Organization as a high-priority pathogen, is a major cause of HAIs, particularly due to its ability to form resilient biofilms on medical devices and host tissues <TextLink reference="10"></TextLink>. The formation and maturation of <Mark2>S. aureus</Mark2> biofilms are primarily mediated by the polysaccharide intercellular adhesion (PIA) system, encoded by the <Mark2>icaADBC</Mark2> operon <TextLink reference="11"></TextLink>. Among the key genes, <Mark2>icaA</Mark2> encodes an N-acetylglucosaminyltransferase essential for polysaccharide synthesis, while <Mark2>icaD</Mark2> acts as a chaperone supporting biofilm formation. Regulatory elements, such as <Mark2>icaR</Mark2>, modulate the expression of these structural genes, influencing the robustness of biofilm development <TextLink reference="12"></TextLink>, <TextLink reference="13"></TextLink>.</Pgraph><Pgraph><Mark2>Acinetobacter (A.) baumannii</Mark2> is a formidable opportunistic pathogen responsible for severe HAIs and is often multidrug-resistant (MDR) <TextLink reference="14"></TextLink>. Its pathogenicity is strongly associated with the formation of antimicrobial-resistant biofilms, which facilitate persistent colonization and horizontal transfer of resistance genes <TextLink reference="15"></TextLink>. Critical biofilm-associated virulence factors in <Mark2>A. baumannii</Mark2> include the biofilm-associated protein <Mark2>(Bap)</Mark2>, which mediates cell-cell adhesion, and the outer membrane protein A <Mark2>(OmpA)</Mark2>, which promotes adherence to biotic and abiotic surfaces, thereby contributing to both biofilm integrity and infection persistence <TextLink reference="16"></TextLink>, <TextLink reference="17"></TextLink>, <TextLink reference="18"></TextLink>.</Pgraph><Pgraph>Despite the recognized antimicrobial activity of certain nanoparticles, the specific effects of green-synthesized QDs on biofilm-associated gene regulation in clinical isolates remain largely unexplored <TextLink reference="19"></TextLink>. In this study, we synthesized silver and copper QDs using an eco-friendly hydrothermal method with oak fruit extract and evaluated their antibiofilm efficacy against strong biofilm-producing clinical isolates of <Mark2>S. aureus</Mark2> and <Mark2>A.</Mark2> <Mark2>baumannii</Mark2>. Importantly, we aimed to elucidate the molecular mechanisms underlying this activity by assessing the impact of sub-inhibitory concentrations of these QDs on the expression of pivotal biofilm-related genes, including <Mark2>icaA, icaD</Mark2>, and <Mark2>icaR</Mark2> in <Mark2>S. aureus</Mark2>, and <Mark2>bap</Mark2> and <Mark2>ompA</Mark2> in <Mark2>A. baumannii</Mark2> <TextLink reference="20"></TextLink>, <TextLink reference="21"></TextLink>. This approach not only investigates the therapeutic potential of QDs but also provides insights into their role in controlling biofilm-associated virulence, with potential applications in reducing the burden of HAIs and improving infection prevention strategies (Figure 1 <ImgLink imgNo="1" imgType="figure" />) <TextLink reference="22"></TextLink>.</Pgraph></TextBlock>
    <TextBlock name="Materials and methods" linked="yes">
      <MainHeadline>Materials and methods</MainHeadline><SubHeadline>Bacterial strains and growth conditions </SubHeadline><Pgraph>A total of 46 <Mark2>S. aureus</Mark2> and 34 <Mark2>A. baumannii</Mark2> clinical isolates were obtained from diabetic, burn, and surgical wound infections at Razi Hospital between June and December 2023. All isolates were identified using standard biochemical and microbiological tests, including catalase, oxidase, and citrate utilization assays. Reference strains <Mark2>A. baumannii</Mark2> (PTCC 1797) and <Mark2>S. aureus</Mark2> (ATCC 29213) were included as controls. Bacterial cultures were maintained on nutrient agar and stored at 4&#176;C until further use.</Pgraph><SubHeadline>Synthesis of quantum dots </SubHeadline><Pgraph>Carbon quantum dots (CQDs) were synthesized from oak fruit using a hydrothermal method. Fresh oak fruits were thoroughly washed with deionized water and acetone, air-dried, and ground into a fine powder. Five grams of powder were added to 100 mL deionized water and boiled with vigorous stirring for 30 minutes. The mixture was centrifuged at 5,000 rpm for 15 minutes to obtain a biphasic solution. The supernatant was filtered through Whatman No. 1 filter paper. Formation of CQDs was confirmed via green fluorescence under a TLC-UV chamber. The remaining solution was transferred to an autoclave and heated at 190&#176;C for 5 hours. After cooling to room temperature, the yellow suspension was oven-dried at 80&#176;C for 2 hours to yield a crystalline brown powder, stored at 4&#176;C for further use.</Pgraph><Pgraph>Silver quantum dots (Ag-QDs) were synthesized by adding 20 mL of 1 mM AgNO3 solution dropwise (approximately one drop per second) to 20 mL of oak fruit colloidal solution (0.01 mg&#47;mL) under constant stirring. The reducing agents in the colloid reduced Ag<Superscript>&#43;</Superscript> to Ag-QDs. After complete addition, the solution was kept in darkness to prevent photochemical reactions. A color change from reddish-brown to yellowish-brown within 1 hour indicated nanoparticle formation. Absorption spectra were recorded at 30&#176;C using a UV-Vis spectrometer. The solution was purified by centrifugation at 10,000 rpm for 10 minutes, and the pellet was dried in an oven at 60&#176;C for 24 hours.</Pgraph><Pgraph>Copper quantum dots (Cu-QDs) were prepared by adding 20 mL of 0.1 M CuSO4 solution to 20 mL of oak fruit extract under continuous stirring at 70&#176;C for 20 minutes. Sodium hydroxide (1 M) was added dropwise to adjust the pH to 12. The solution color transitioned from blue to green, dark green, and finally to dark brown, indicating formation of Cu-based QDs. Brown particles were collected by double centrifugation at 12,000 rpm for 10 minutes each and dried in an oven at 60&#176;C for 24 hours.</Pgraph><SubHeadline>Characterization of quantum dots </SubHeadline><Pgraph>The absorption spectra of synthesized QDs were recorded using an Agilent UV-Vis spectrometer (200&#8211;700 nm) 120 minutes after synthesis (Figure 2 <ImgLink imgNo="2" imgType="figure" />). </Pgraph><Pgraph>Transmission electron microscopy (TEM): TEM (Zeiss EM10C) was used to determine the morphology and size distribution of the QDs (Figure 3 <ImgLink imgNo="3" imgType="figure" />).</Pgraph><SubHeadline>Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) </SubHeadline><Pgraph>MIC and MBC were determined using the broth microdilution method following CLSI guidelines <TextLink reference="23"></TextLink>. Briefly, bacterial strains were cultured in Mueller-Hinton broth (MHB) at 37&#176;C for 24 hours with shaking at 120 rpm. Serial dilutions of Ag-QDs and Cu-QDs (50&#8211;400 &#181;g&#47;mL) were dispensed into 96-well microplates (50 &#181;L per well), and each well was inoculated with 5 &#181;L of bacterial suspension adjusted to 0.5 McFarland standard. Wells containing bacteria without QDs served as growth controls. MIC was defined as the lowest concentration completely inhibiting visible growth. Sub-MIC concentrations (immediately below MIC) were used for subsequent biofilm and gene expression experiments.</Pgraph><SubHeadline>Biofilm formation and antibiofilm assay </SubHeadline><Pgraph>Biofilm formation was assessed using the microtiter plate method as described by Lee et al. <TextLink reference="21"></TextLink> with optical density (OD) measurements. Each isolate was tested in triplicate. Isolates were classified based on OD values: </Pgraph><Pgraph><UnorderedList><ListItem level="1">No biofilm producer: OD&#8804;ODc</ListItem><ListItem level="1">Weak biofilm producer: ODc&#60;OD&#8804;2&#215;ODc</ListItem><ListItem level="1">Moderate biofilm producer: 2&#215;ODc&#60;OD&#8804;4&#215;ODc</ListItem><ListItem level="1">Strong biofilm producer: OD&#62;4&#215;ODc.</ListItem></UnorderedList></Pgraph><Pgraph>Five strong biofilm-producing isolates each of <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2> were selected for treatment with QDs.</Pgraph><SubHeadline>RNA extraction and cDNA synthesis </SubHeadline><Pgraph>Total RNA was extracted from isolates treated with sub-MIC concentrations of QDs using a commercial RNA extraction kit (Qiagen, Germany) according to the manufacturer&#8217;s protocol. Single colonies were inoculated into 5 mL LB broth and incubated at 37&#176;C for 24 hours. Then, 100 &#181;L of culture were transferred to 10 mL fresh LB broth and grown to mid-lg phase (OD<Subscript>600</Subscript> &#8776;0.5) at 37&#176;C with shaking at 185 rpm. RNA quantity and purity were assessed spectrophotometrically at 260, 280, and 230 nm to ensure absence of protein, salt, or other contaminants. Purity ratios (A260&#47;A280 and A260&#47;A230) were within acceptable ranges. Approximately 500 ng of RNA was reverse-transcribed into cDNA using the RT&#8482; Script Prime kit (Takara, Japan).</Pgraph><SubHeadline>Quantitative real-ime PCR (qRT-PCR) </SubHeadline><Pgraph>qRT-PCR was performed using SYBR Green master mix (Applied Biosystems, UK). Gene-specific primers for <Mark2>bap, ompA ompA, icaA, icaD</Mark2>, and <Mark2>icaR</Mark2> were designed using Primer Express and Gene Runner software, and specificity was verified via NCBI BLAST. The 16S <Mark2>rRNA</Mark2> gene was used as an internal reference. Reactions were prepared in 25 &#181;L volumes, containing 2 &#181;L cDNA template, 10 pM of each forward and reverse primer, 1 &#181;L Bioneer master mix, and nuclease-free water to 25 &#181;L. Amplification was performed on a Bioneer Exicycler 96 with the following thermal profile: </Pgraph><Pgraph><UnorderedList><ListItem level="1">Initial denaturation: 95&#176;C for 10 min</ListItem><ListItem level="1">40 cycles: 95&#176;C for 20 s, 58&#176;C for 40 s</ListItem><ListItem level="1">Melting curve: 95&#176;C for 15 s, 60&#176;C for 30 s, 95&#176;C for 15 s</ListItem></UnorderedList></Pgraph><Pgraph>All reactions were performed in duplicate. Relative gene expression was calculated using the 2<Superscript>&#94;</Superscript>&#8211;&#8710;&#8710;Ct method. Table 1 <ImgLink imgNo="1" imgType="table" /> shows the sequence of forward and reverse primer pairs of <Mark2>bap, ompA</Mark2>, and <Mark2>ica A, D, R</Mark2> genes.</Pgraph><SubHeadline>Statistical analysis </SubHeadline><Pgraph>All statistical analyses were performed using SPSS version 18 (SPSS Inc., Chicago, IL, USA). Gene expression data were analyzed using one-way ANOVA followed by Tukey&#8217;s post hoc test for multiple <Mark2>comparisons</Mark2>. Differences with p-values &#60;0.05 were considered statistically significant. </Pgraph></TextBlock>
    <TextBlock name="Results" linked="yes">
      <MainHeadline>Results</MainHeadline><SubHeadline>Biofilm production </SubHeadline><Pgraph>Among the clinical isolates screened, 36 <Mark2>S. aureus</Mark2> and 34 <Mark2>A. baumannii</Mark2> strains were evaluated for their biofilm-forming capacity using the microtiter plate assay. Five isolates from each species, identified as strong biofilm producers, were selected for subsequent experiments. Isolates exhibiting weak or moderate biofilm formation were excluded from further analyses to focus on the most virulent biofilm-forming strains. The distribution of biofilm production ability among <Mark2>S. aureus</Mark2> isolates from different clinical samples is detailed in Table 2 <ImgLink imgNo="2" imgType="table" />. Similarly, the biofilm formation capacity of <Mark2>A. baumannii</Mark2> isolates is summarized in Table 3 <ImgLink imgNo="3" imgType="table" />.</Pgraph><SubHeadline>MIC and sub-MIC of silver and copper QDs </SubHeadline><Pgraph>The MIC values for the selected strong biofilm-producing isolates were determined to be 300 &#181;g&#47;mL for Ag-QDs and 400 &#181;g&#47;mL for Cu-QDs for both <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2>. Based on these results, sub-MIC concentrations were defined as 200 &#181;g&#47;mL for Ag-QDs and 300 &#181;g&#47;mL for Cu-QDs. These concentrations were used for subsequent antibiofilm and gene expression experiments to assess the effects of QDs without completely inhibiting bacterial growth (Figure 3 <ImgLink imgNo="3" imgType="figure" />).</Pgraph><SubHeadline>Anti-biofilm activities of silver and copper QDs </SubHeadline><Pgraph>Both Ag-QDs and Cu-QDs demonstrated significant antibiofilm activity against all isolates. Complete inhibition of biofilm formation was observed at concentrations &#8805;300 &#181;g&#47;mL for Ag-QDs and &#8805;400 &#181;g&#47;mL for Cu-QDs, as indicated by optical density measurements below the cut-off value (ODc&#61;0.22). Reference strains exhibited similar susceptibility patterns, confirming the reproducibility and consistency of the results. Sub-MIC concentrations of QDs significantly reduced biofilm biomass, indicating effective antibiofilm activity even at non-lethal concentrations.</Pgraph><Pgraph>Effect of sub-MIC concentrations of QDs on biofilm-related gene expression: Quantitative real-time PCR analysis revealed that treatment with sub-MIC concentrations of both Ag-QDs and Cu-QDs significantly downregulated the expression of key biofilm-associated genes in both bacterial species. In<Mark2> S. aureus</Mark2>, expression levels of<Mark2> icaA, icaD</Mark2>, and <Mark2>icaR</Mark2> were markedly decreased (p&#60;0.05) following treatment with QDs. Ag-QDs consistently demonstrated a more pronounced inhibitory effect on these genes compared to Cu-QDs. In <Mark2>A. baumannii</Mark2>, <Mark2>bap</Mark2> and <Mark2>ompA</Mark2> gene expression was significantly reduced under sub-MIC QD treatment (p&#60;0.05). Ag-QDs again exhibited stronger suppression of gene expression than Cu-QDs.</Pgraph><SubHeadline>Real-time PCR assessment of icaA and icaD expression in S. aureus </SubHeadline><Pgraph>The analysis of gene expression revealed a statistically significant decrease in <Mark2>icaA</Mark2>, <Mark2>icaD</Mark2>, and <Mark2>icaR</Mark2> levels in <Mark2>S. aureus</Mark2> following treatment with Ag-QDs and Cu-QDs compared to untreated controls (p&#60;0.05). Notably, Ag-QDs exerted a stronger inhibitory effect on gene expression than Cu-QDs across all tested isolates (Figure 4 <ImgLink imgNo="4" imgType="figure" />). </Pgraph></TextBlock>
    <TextBlock name="Discussion" linked="yes">
      <MainHeadline>Discussion</MainHeadline><Pgraph><Mark2>A. baumannii</Mark2> represents a particularly formidable pathogen, with its rising prevalence in healthcare settings and extensive drug resistance profiles contributing substantially to patient morbidity and mortality <TextLink reference="24"></TextLink>, <TextLink reference="25"></TextLink>, <TextLink reference="26"></TextLink>. Despite its recognized clinical significance, the ecology and transmission dynamics of <Mark2>A. baumannii</Mark2> in non-hospital environments remain insufficiently understood <TextLink reference="24"></TextLink>, <TextLink reference="25"></TextLink>. Similarly, <Mark2>S. aureus</Mark2> continues to be a predominant cause of HAIs, with its ability to develop resistance to multiple antibiotics and form biofilms on medical devices posing major therapeutic challenges. Biofilm formation constitutes a critical virulence mechanism, substantially contributing to multidrug resistance <TextLink reference="26"></TextLink>, <TextLink reference="27"></TextLink>. Chronic biofilm-associated infections result in prolonged treatment, increased mortality, and considerable economic burdens, particularly in developing countries, emphasizing the urgent need for alternative therapeutic strategies <TextLink reference="28"></TextLink>.</Pgraph><Pgraph>Nanotechnology has emerged as a promising approach to address biofilm-related challenges. The application of nanoparticles in antimicrobial research has gained significant attention, resulting in rapid advancement in this field <TextLink reference="29"></TextLink>. Among various nanomaterials, quantum dots (QDs) exhibit unique physicochemical properties and multifunctional antimicrobial capabilities, making them particularly suitable for combating biofilm-associated infections <TextLink reference="30"></TextLink>, <TextLink reference="31"></TextLink>. While previous studies and comprehensive reviews have addressed nanoparticle-based antibiofilm strategies, our study specifically investigates the antibiofilm mechanisms of green-synthesized metallic QDs at the genetic level, representing, to our knowledge, the first report on the effects of silver and copper QDs on the expression of key biofilm-related genes in clinical isolates of <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2> <TextLink reference="29"></TextLink>, <TextLink reference="30"></TextLink>.</Pgraph><Pgraph>In this study, we employed an environmentally friendly synthesis method using oak fruit extract, consistent with the principles of green chemistry <TextLink reference="31"></TextLink>. Both Ag-QDs and Cu-QDs synthesized through this approach demonstrated significant antibacterial and antibiofilm activities against clinical isolates of <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2> <TextLink reference="32"></TextLink>. Importantly, at sub-MIC concentrations, these QDs effectively suppressed the expression of critical biofilm-related genes, with Ag-QDs showing superior efficacy compared to Cu-QDs <TextLink reference="25"></TextLink>, <TextLink reference="28"></TextLink>. The observed MIC values, 300 &#181;g&#47;mL for Ag-QDs and 400 &#181;g&#47;mL for Cu-QDs, are consistent with previous reports indicating the potent antibacterial activity of silver nanoparticles against <Mark2>S. aureus</Mark2> <TextLink reference="27"></TextLink>, <TextLink reference="31"></TextLink>.</Pgraph><Pgraph>Our results extend existing knowledge by providing novel insights into the genetic mechanisms underlying QD-mediated biofilm inhibition <TextLink reference="33"></TextLink>. Quantitative real-time PCR analysis revealed significant downregulation of <Mark2>icaA</Mark2>, <Mark2>icaD</Mark2>, and <Mark2>icaR</Mark2> genes in<Mark2> S. aureus</Mark2>, and <Mark2>bap</Mark2> and <Mark2>ompA</Mark2> genes in <Mark2>A. baumannii</Mark2> following treatment with sub-MIC concentrations of QDs <TextLink reference="34"></TextLink>, <TextLink reference="35"></TextLink>. These findings suggest that QDs interfere with biofilm formation by disrupting key pathways involved in bacterial adhesion, quorum sensing, and extracellular matrix production. Notably, Ag-QDs consistently demonstrated stronger inhibitory effects on gene expression compared to Cu-QDs, highlighting the higher potency of silver-based nanomaterials in antibiofilm applications <TextLink reference="36"></TextLink>, <TextLink reference="23"></TextLink>.</Pgraph><Pgraph>Our findings agree with previous studies showing that metallic nanoparticles are capable of modulating biofilm-associated gene expression. Earlier research has demonstrated that such nanoparticles can alter the expression of genes involved in biofilm formation in <Mark2>S. aureus</Mark2> as well as reduce the expression of key biofilm-related genes in <Mark2>A. baumannii</Mark2> <TextLink reference="31"></TextLink>, <TextLink reference="32"></TextLink>, <TextLink reference="34"></TextLink>. Other studies have also indicated that treatment with metallic nanoparticles leads to a simultaneous decrease in virulence gene expression and biofilm production in multidrug-resistant clinical strains <TextLink reference="18"></TextLink>. The present study confirms and extends these observations by showing that both silver and copper QDs, even at sub-MIC concentrations, exert similar inhibitory effects, supporting their potential as eco-friendly antibiofilm agents against clinical isolates <TextLink reference="37"></TextLink>, <TextLink reference="38"></TextLink>.</Pgraph><Pgraph>The correlation between reduced biofilm formation and downregulation of key virulence genes in both bacterial species provides mechanistic insight into QD-mediated antibiofilm activity. The suppression of icaADR genes in <Mark2>S. aureus</Mark2> and <Mark2>bap&#47;ompA</Mark2> genes in <Mark2>A. baumannii</Mark2> explains the observed reduction in biofilm biomass and highlights the potential of QDs to penetrate biofilm structures and interfere with critical molecular pathways <TextLink reference="26"></TextLink>, <TextLink reference="30"></TextLink>. These findings not only reinforce the potential of metallic QDs as alternative therapeutic agents against resistant pathogens but also suggest a promising strategy for overcoming biofilm-associated antibiotic resistance in clinical settings <TextLink reference="4"></TextLink>, <TextLink reference="29"></TextLink>.</Pgraph><Pgraph>In summary, this study provides evidence that green-synthesized Ag-QDs and Cu-QDs exert significant antibiofilm activity against clinical isolates of <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2> through downregulation of key genetic determinants of biofilm formation, even at sub-inhibitory concentrations. Among the two, Ag-QDs demonstrated consistently superior efficacy, supporting their preferential consideration for further development. </Pgraph><SubHeadline>Limitations</SubHeadline><Pgraph>However, several critical aspects must be addressed before clinical translation. First, while our in vitro findings are mechanistically informative, they do not account for the complex host&#8211;pathogen&#8211;nanomaterial interactions present in vivo. Second, the long-term biocompatibility and potential cytotoxicity of these QDs, particularly upon repeated administration, remain to be systematically evaluated. Third, the emergence of bacterial tolerance to sub-MIC levels of QDs, though not observed in our short-term assays, warrants investigation through longitudinal exposure studies. From a translational perspective, future research should prioritize in vivo efficacy testing in appropriate animal models, pharmacokinetic and biodistribution profiling, and formulation development to enhance targeted delivery to biofilm-infected tissues. Additionally, combination strategies with conventional antibiotics or biofilm-disrupting enzymes could be explored to achieve synergistic effects and reduce the risk of resistance. Ultimately, addressing these knowledge gaps will be essential to determine whether QD-based therapies can be safely and effectively integrated into clinical practice as adjuncts or alternatives to current antibiotic regimens <TextLink reference="7"></TextLink>, <TextLink reference="15"></TextLink>, <TextLink reference="20"></TextLink>.</Pgraph></TextBlock>
    <TextBlock name="Conclusions" linked="yes">
      <MainHeadline>Conclusions</MainHeadline><Pgraph>This study demonstrates that green-synthesized silver and copper quantum dots exhibit potent antibiofilm activity against clinical isolates of <Mark2>S. aureus</Mark2> and <Mark2>A. baumannii</Mark2>. The observed antibiofilm effects are mediated, at least in part, through the downregulation of key virulence genes involved in biofilm formation, specifically the <Mark2>icaADR</Mark2> operon in <Mark2>S. aureus</Mark2> and <Mark2>bap&#47;ompA</Mark2> genes in <Mark2>A. baumannii</Mark2>. Silver QDs consistently showed superior efficacy compared to copper QDs in suppressing both biofilm formation and virulence gene expression. These findings underscore the potential of metallic quantum dots as promising anti-biofilm agents for combating infections caused by multidrug-resistant pathogens. Future studies should investigate additional genes involved in biofilm regulation and assess the in vivo efficacy and safety of these nanoparticles.</Pgraph></TextBlock>
    <TextBlock name="Notes" linked="yes">
      <MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph><SubHeadline>Authors&#8217; ORCIDs </SubHeadline><Pgraph><UnorderedList><ListItem level="1">Nabipour YS: <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0003-0504-586">https:&#47;&#47;orcid.org&#47;0000-0003-0504-586</Hyperlink></ListItem><ListItem level="1">Hesampour A : <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-7324-5469">https:&#47;&#47;orcid.org&#47;0000-0002-7324-5469</Hyperlink></ListItem><ListItem level="1">Asbchin SA : <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0001-6079-1842">https:&#47;&#47;orcid.org&#47;0000-0001-6079-1842</Hyperlink></ListItem><ListItem level="1">Tajabadi M : <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0003-2780-3447">https:&#47;&#47;orcid.org&#47;0000-0003-2780-3447</Hyperlink></ListItem><ListItem level="1">Rostamza A  : <Hyperlink href="https:&#47;&#47;orcid.org&#47;0000-0002-2288-3794">https:&#47;&#47;orcid.org&#47;0000-0002-2288-3794</Hyperlink></ListItem></UnorderedList></Pgraph><SubHeadline>Ethical approval </SubHeadline><Pgraph>Animal experiments were conducted following the ethical guidelines approved by the Animal Ethics Committee of Tehran University of Medical Sciences (Ethics code: IR.ILAM.REC.1401.008). All in vivo procedures were performed in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and the national guidelines of Iran for the ethical use of animals in research.</Pgraph><SubHeadline>Funding </SubHeadline><Pgraph>None. </Pgraph></TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>Nguyen MH</RefAuthor>
        <RefAuthor>Le AT</RefAuthor>
        <RefAuthor>Pham VD</RefAuthor>
        <RefAuthor>Pham HM</RefAuthor>
        <RefAuthor>Do HT</RefAuthor>
        <RefAuthor>Le DT</RefAuthor>
        <RefAuthor></RefAuthor>
        <RefTitle>A Comprehensive study on the antibacterial activities of carbon quantum dots derived from orange juice against Escherichia coli</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Appl Sci</RefJournal>
        <RefPage>10</RefPage>
        <RefTotal>Nguyen MH, Le AT, Pham VD, Pham HM, Do HT, Le DT, et al. A Comprehensive study on the antibacterial activities of carbon quantum dots derived from orange juice against Escherichia coli. Appl Sci. 2024 March 16;14(6):2509. DOI:10.3390&#47;app14062509</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;app14062509</RefLink>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Koul K</RefAuthor>
        <RefAuthor>Jawanda IK</RefAuthor>
        <RefAuthor>Soni T</RefAuthor>
        <RefAuthor>Singh P</RefAuthor>
        <RefAuthor>Sharma D</RefAuthor>
        <RefAuthor>Kumari S</RefAuthor>
        <RefTitle>Quantum dots: a next generation approach for pathogenic microbial biofilm inhibition; mechanistic insights, existing challenges, and future potential</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Arch Microbiol</RefJournal>
        <RefPage>158</RefPage>
        <RefTotal>Koul K, Jawanda IK, Soni T, Singh P, Sharma D, Kumari S. Quantum dots: a next generation approach for pathogenic microbial biofilm inhibition; mechanistic insights, existing challenges, and future potential. Arch Microbiol. 2024 Mar;206(4):158. DOI: 10.1007&#47;s00203-024-03919-3</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1007&#47;s00203-024-03919-3</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Cepas V</RefAuthor>
        <RefAuthor>Soto SM</RefAuthor>
        <RefTitle>Relationship between biofilm formation and antimicrobial resistance in Gram-negative bacteria</RefTitle>
        <RefYear>Feb</RefYear>
        <RefJournal>Microb Drug Resist</RefJournal>
        <RefPage>10.1089&#47;mdr.2019</RefPage>
        <RefTotal>Cepas V, Soto SM. Relationship between biofilm formation and antimicrobial resistance in Gram-negative bacteria. Microb Drug Resist. Feb 9; 2020;26(8):1017-33. DOI:10.1089&#47;mdr.2019.0173</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1089&#47;mdr.2019.0173</RefLink>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Khatoon Z</RefAuthor>
        <RefAuthor>McTiernan CD</RefAuthor>
        <RefAuthor>Suuronen EJ</RefAuthor>
        <RefAuthor>Mah TF</RefAuthor>
        <RefAuthor>Alarcon EI</RefAuthor>
        <RefTitle>Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Heliyon</RefJournal>
        <RefPage>e01067</RefPage>
        <RefTotal>Khatoon Z, McTiernan CD, Suuronen EJ, Mah TF, Alarcon EI. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon. 2018 Dec;4(12):e01067. DOI: 10.1016&#47;j.heliyon.2018.e01067</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.heliyon.2018.e01067</RefLink>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Costa MO</RefAuthor>
        <RefAuthor>Beltrame CO</RefAuthor>
        <RefAuthor>Ferreira FA</RefAuthor>
        <RefAuthor>Botelho AM</RefAuthor>
        <RefAuthor>Lima NC</RefAuthor>
        <RefAuthor>Souza RC</RefAuthor>
        <RefAuthor>de Almeida LG</RefAuthor>
        <RefAuthor>Vasconcelos AT</RefAuthor>
        <RefAuthor>Nicol&#225;s MF</RefAuthor>
        <RefAuthor>Figueiredo AM</RefAuthor>
        <RefTitle>Complete Genome Sequence of a Variant of the Methicillin-Resistant Staphylococcus aureus ST239 Lineage, Strain BMB9393, Displaying Superior Ability To Accumulate ica-Independent Biofilm</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>Genome Announc</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Costa MO, Beltrame CO, Ferreira FA, Botelho AM, Lima NC, Souza RC, de Almeida LG, Vasconcelos AT, Nicol&#225;s MF, Figueiredo AM. Complete Genome Sequence of a Variant of the Methicillin-Resistant Staphylococcus aureus ST239 Lineage, Strain BMB9393, Displaying Superior Ability To Accumulate ica-Independent Biofilm. Genome Announc. 2013 Aug;1(4):. DOI: 10.1128&#47;genomeA.00576-13</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;genomeA.00576-13</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>Abd El-Rahman OA</RefAuthor>
        <RefAuthor>Rasslan F</RefAuthor>
        <RefAuthor>Hassan SS</RefAuthor>
        <RefAuthor>Ashour HM</RefAuthor>
        <RefAuthor>Wasfi R</RefAuthor>
        <RefTitle>The RND Efflux Pump Gene Expression in the Biofilm Formation of</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Antibiotics (Basel)</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Abd El-Rahman OA, Rasslan F, Hassan SS, Ashour HM, Wasfi R. The RND Efflux Pump Gene Expression in the Biofilm Formation of. Antibiotics (Basel). 2023 Feb;12(2):. DOI: 10.3390&#47;antibiotics12020419</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;antibiotics12020419</RefLink>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Brossard KA</RefAuthor>
        <RefAuthor>Campagnari AA</RefAuthor>
        <RefTitle>The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells</RefTitle>
        <RefYear>2012</RefYear>
        <RefJournal>Infect Immun</RefJournal>
        <RefPage>228-33</RefPage>
        <RefTotal>Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun. 2012 Jan;80(1):228-33. DOI: 10.1128&#47;IAI.05913-11</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;IAI.05913-11</RefLink>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>McConnell MJ</RefAuthor>
        <RefAuthor>Actis L</RefAuthor>
        <RefAuthor>Pach&#243;n J</RefAuthor>
        <RefTitle>Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models</RefTitle>
        <RefYear>2013</RefYear>
        <RefJournal>FEMS Microbiol Rev</RefJournal>
        <RefPage>130-55</RefPage>
        <RefTotal>McConnell MJ, Actis L, Pach&#243;n J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev. 2013 Mar;37(2):130-55. DOI: 10.1111&#47;j.1574-6976.2012.00344.x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;j.1574-6976.2012.00344.x</RefLink>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>Hosnedlova B</RefAuthor>
        <RefAuthor>Kabanov D</RefAuthor>
        <RefAuthor>Kepinska M</RefAuthor>
        <RefAuthor>B Narayanan VH</RefAuthor>
        <RefAuthor>Parikesit AA</RefAuthor>
        <RefAuthor>Fernandez C</RefAuthor>
        <RefAuthor>Bj&#248;rklund G</RefAuthor>
        <RefAuthor>Nguyen HV</RefAuthor>
        <RefAuthor>Farid A</RefAuthor>
        <RefAuthor>Sochor J</RefAuthor>
        <RefAuthor>Pholosi A</RefAuthor>
        <RefAuthor>Baron M</RefAuthor>
        <RefAuthor>Jakubek M</RefAuthor>
        <RefAuthor>Kizek R</RefAuthor>
        <RefTitle>Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in and</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Nanomaterials (Basel)</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Hosnedlova B, Kabanov D, Kepinska M, B Narayanan VH, Parikesit AA, Fernandez C, Bj&#248;rklund G, Nguyen HV, Farid A, Sochor J, Pholosi A, Baron M, Jakubek M, Kizek R. Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in and. Nanomaterials (Basel). 2022 Jun;12(13):. DOI: 10.3390&#47;nano12132183</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;nano12132183</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Al-Wrafy FA</RefAuthor>
        <RefAuthor>Al-Gheethi AA</RefAuthor>
        <RefAuthor>Ponnusamy SK</RefAuthor>
        <RefAuthor>Noman EA</RefAuthor>
        <RefAuthor>Fattah SA</RefAuthor>
        <RefTitle>Nanoparticles approach to eradicate bacterial biofilm-related infections: A critical review</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Chemosphere</RefJournal>
        <RefPage>132603</RefPage>
        <RefTotal>Al-Wrafy FA, Al-Gheethi AA, Ponnusamy SK, Noman EA, Fattah SA. Nanoparticles approach to eradicate bacterial biofilm-related infections: A critical review. Chemosphere. 2022 Feb;288(Pt 2):132603. DOI: 10.1016&#47;j.chemosphere.2021.132603</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.chemosphere.2021.132603</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Wu J</RefAuthor>
        <RefAuthor>Zhang B</RefAuthor>
        <RefAuthor>Lin N</RefAuthor>
        <RefAuthor>Gao J</RefAuthor>
        <RefTitle>Recent nanotechnology-based strategies for interfering with the life cycle of bacterial biofilms</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Biomater Sci</RefJournal>
        <RefPage>1648-1664</RefPage>
        <RefTotal>Wu J, Zhang B, Lin N, Gao J. Recent nanotechnology-based strategies for interfering with the life cycle of bacterial biofilms. Biomater Sci. 2023 Feb;11(5):1648-1664. DOI: 10.1039&#47;d2bm01783k</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1039&#47;d2bm01783k</RefLink>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Afrasiabi S</RefAuthor>
        <RefAuthor>Partoazar A</RefAuthor>
        <RefTitle>Targeting bacterial biofilm-related genes with nanoparticle-based strategies</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Front Microbiol</RefJournal>
        <RefPage>1387114</RefPage>
        <RefTotal>Afrasiabi S, Partoazar A. Targeting bacterial biofilm-related genes with nanoparticle-based strategies. Front Microbiol. 2024;15:1387114. DOI: 10.3389&#47;fmicb.2024.1387114</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fmicb.2024.1387114</RefLink>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Ahuatzin-Flores OE</RefAuthor>
        <RefAuthor>Torres E</RefAuthor>
        <RefAuthor>Ch&#225;vez-Bravo E</RefAuthor>
        <RefTitle>A Multidrug-Resistant Opportunistic Pathogen in New Habitats: A Systematic Review</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Microorganisms</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Ahuatzin-Flores OE, Torres E, Ch&#225;vez-Bravo E. A Multidrug-Resistant Opportunistic Pathogen in New Habitats: A Systematic Review. Microorganisms. 2024 Mar;12(4):. DOI: 10.3390&#47;microorganisms12040644</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;microorganisms12040644</RefLink>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Pourkhosravani E</RefAuthor>
        <RefAuthor>Dehghan Nayeri F</RefAuthor>
        <RefAuthor>Mohammadi Bazargani M</RefAuthor>
        <RefTitle>Decoding antibacterial and antibiofilm properties of cinnamon and cardamom essential oils: a combined molecular docking and experimental study</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>AMB Express</RefJournal>
        <RefPage>143</RefPage>
        <RefTotal>Pourkhosravani E, Dehghan Nayeri F, Mohammadi Bazargani M. Decoding antibacterial and antibiofilm properties of cinnamon and cardamom essential oils: a combined molecular docking and experimental study. AMB Express. 2021 Oct;11(1):143. DOI: 10.1186&#47;s13568-021-01305-6</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s13568-021-01305-6</RefLink>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Asadi S</RefAuthor>
        <RefAuthor>Nayeri-Fasaei B</RefAuthor>
        <RefAuthor>Zahraei-Salehi T</RefAuthor>
        <RefAuthor>Yahya-Rayat R</RefAuthor>
        <RefAuthor>Shams N</RefAuthor>
        <RefAuthor>Sharifi A</RefAuthor>
        <RefTitle>Antibacterial and anti-biofilm properties of carvacrol alone and in combination with cefixime against Escherichia coli</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>BMC Microbiol</RefJournal>
        <RefPage>55</RefPage>
        <RefTotal>Asadi S, Nayeri-Fasaei B, Zahraei-Salehi T, Yahya-Rayat R, Shams N, Sharifi A. Antibacterial and anti-biofilm properties of carvacrol alone and in combination with cefixime against Escherichia coli. BMC Microbiol. 2023 Mar;23(1):55. DOI: 10.1186&#47;s12866-023-02797-x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12866-023-02797-x</RefLink>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Wang Z</RefAuthor>
        <RefAuthor>Shen Y</RefAuthor>
        <RefAuthor>Haapasalo M</RefAuthor>
        <RefTitle>Antimicrobial and Antibiofilm Properties of Bioceramic Materials in Endodontics</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Materials (Basel)</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Wang Z, Shen Y, Haapasalo M. Antimicrobial and Antibiofilm Properties of Bioceramic Materials in Endodontics. Materials (Basel). 2021 Dec;14(24):. DOI: 10.3390&#47;ma14247594</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;ma14247594</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Kakavan M</RefAuthor>
        <RefAuthor>Gholami M</RefAuthor>
        <RefAuthor>Ahanjan M</RefAuthor>
        <RefAuthor>Ebrahimzadeh MA</RefAuthor>
        <RefAuthor>Salehian M</RefAuthor>
        <RefAuthor>Roozbahani F</RefAuthor>
        <RefAuthor>Goli HR</RefAuthor>
        <RefTitle>Expression of bap gene in multidrug-resistant and biofilm-producing Acinetobacter baumannii clinical isolates</RefTitle>
        <RefYear>2025</RefYear>
        <RefJournal>BMC Microbiol</RefJournal>
        <RefPage>108</RefPage>
        <RefTotal>Kakavan M, Gholami M, Ahanjan M, Ebrahimzadeh MA, Salehian M, Roozbahani F, Goli HR. Expression of bap gene in multidrug-resistant and biofilm-producing Acinetobacter baumannii clinical isolates. BMC Microbiol. 2025 Mar;25(1):108. DOI: 10.1186&#47;s12866-025-03806-x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12866-025-03806-x</RefLink>
      </Reference>
      <Reference refNo="18">
        <RefAuthor>Hetta HF</RefAuthor>
        <RefAuthor>Al-Kadmy IMS</RefAuthor>
        <RefAuthor>Khazaal SS</RefAuthor>
        <RefAuthor>Abbas S</RefAuthor>
        <RefAuthor>Suhail A</RefAuthor>
        <RefAuthor>El-Mokhtar MA</RefAuthor>
        <RefAuthor>Ellah NHA</RefAuthor>
        <RefAuthor>Ahmed EA</RefAuthor>
        <RefAuthor>Abd-Ellatief RB</RefAuthor>
        <RefAuthor>El-Masry EA</RefAuthor>
        <RefAuthor>Batiha GE</RefAuthor>
        <RefAuthor>Elkady AA</RefAuthor>
        <RefAuthor>Mohamed NA</RefAuthor>
        <RefAuthor>Algammal AM</RefAuthor>
        <RefTitle>Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii</RefTitle>
        <RefYear>2021</RefYear>
        <RefJournal>Sci Rep</RefJournal>
        <RefPage>10751</RefPage>
        <RefTotal>Hetta HF, Al-Kadmy IMS, Khazaal SS, Abbas S, Suhail A, El-Mokhtar MA, Ellah NHA, Ahmed EA, Abd-Ellatief RB, El-Masry EA, Batiha GE, Elkady AA, Mohamed NA, Algammal AM. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii. Sci Rep. 2021 May;11(1):10751. DOI: 10.1038&#47;s41598-021-90208-4</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;s41598-021-90208-4</RefLink>
      </Reference>
      <Reference refNo="19">
        <RefAuthor>Rezania N</RefAuthor>
        <RefAuthor>Rahmati P</RefAuthor>
        <RefAuthor>Noorbakhsh F</RefAuthor>
        <RefAuthor>Farhadyar N</RefAuthor>
        <RefAuthor>Lotfali E</RefAuthor>
        <RefTitle>Investigation the effects of silver nanoparticles and gold nanoparticles on expression of and genes in biofilm formation of</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Iran J Microbiol</RefJournal>
        <RefPage>510-517</RefPage>
        <RefTotal>Rezania N, Rahmati P, Noorbakhsh F, Farhadyar N, Lotfali E. Investigation the effects of silver nanoparticles and gold nanoparticles on expression of and genes in biofilm formation of. Iran J Microbiol. 2022 Aug;14(4):510-517. DOI: 10.18502&#47;ijm.v14i4.10237</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.18502&#47;ijm.v14i4.10237</RefLink>
      </Reference>
      <Reference refNo="20">
        <RefAuthor>Valadbeigi H</RefAuthor>
        <RefAuthor>Sadeghifard N</RefAuthor>
        <RefAuthor>Kaviar VH</RefAuthor>
        <RefAuthor>Haddadi MH</RefAuthor>
        <RefAuthor>Ghafourian S</RefAuthor>
        <RefAuthor>Maleki A</RefAuthor>
        <RefTitle>Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>Ann Clin Microbiol Antimicrob</RefJournal>
        <RefPage>89</RefPage>
        <RefTotal>Valadbeigi H, Sadeghifard N, Kaviar VH, Haddadi MH, Ghafourian S, Maleki A. Effect of ZnO nanoparticles on biofilm formation and gene expression of the toxin-antitoxin system in clinical isolates of Pseudomonas aeruginosa. Ann Clin Microbiol Antimicrob. 2023 Oct;22(1):89. DOI: 10.1186&#47;s12941-023-00639-2</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12941-023-00639-2</RefLink>
      </Reference>
      <Reference refNo="21">
        <RefAuthor>Lee B</RefAuthor>
        <RefAuthor>Schjerling CK</RefAuthor>
        <RefAuthor>Kirkby N</RefAuthor>
        <RefAuthor>Hoffmann N</RefAuthor>
        <RefAuthor>Borup R</RefAuthor>
        <RefAuthor>Molin S</RefAuthor>
        <RefAuthor>H&#248;iby N</RefAuthor>
        <RefAuthor>Ciofu O</RefAuthor>
        <RefTitle>Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients</RefTitle>
        <RefYear>2011</RefYear>
        <RefJournal>APMIS</RefJournal>
        <RefPage>263-74</RefPage>
        <RefTotal>Lee B, Schjerling CK, Kirkby N, Hoffmann N, Borup R, Molin S, H&#248;iby N, Ciofu O. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. APMIS. 2011 Apr;119(4-5):263-74. DOI: 10.1111&#47;j.1600-0463.2011.02726.x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1111&#47;j.1600-0463.2011.02726.x</RefLink>
      </Reference>
      <Reference refNo="22">
        <RefAuthor>Balouiri M</RefAuthor>
        <RefAuthor>Sadiki M</RefAuthor>
        <RefAuthor>Ibnsouda SK</RefAuthor>
        <RefTitle>Methods for evaluating antimicrobial activity: A review</RefTitle>
        <RefYear>2016</RefYear>
        <RefJournal>J Pharm Anal</RefJournal>
        <RefPage>71-79</RefPage>
        <RefTotal>Balouiri M, Sadiki M, Ibnsouda SK. Methods for evaluating antimicrobial activity: A review. J Pharm Anal. 2016 Apr;6(2):71-79. DOI: 10.1016&#47;j.jpha.2015.11.005</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.jpha.2015.11.005</RefLink>
      </Reference>
      <Reference refNo="24">
        <RefAuthor>Shawky M</RefAuthor>
        <RefAuthor>Kalaba MH</RefAuthor>
        <RefAuthor>El-Sherbiny GM</RefAuthor>
        <RefTitle>Tackling carbapenem-resistant (CRAB) and their virulence factors using biosynthesized silver nanoparticles combined with imipenem</RefTitle>
        <RefYear>2025</RefYear>
        <RefJournal>Biotechnol Notes</RefJournal>
        <RefPage>183-195</RefPage>
        <RefTotal>Shawky M, Kalaba MH, El-Sherbiny GM. Tackling carbapenem-resistant (CRAB) and their virulence factors using biosynthesized silver nanoparticles combined with imipenem. Biotechnol Notes. 2025;6:183-195. DOI: 10.1016&#47;j.biotno.2025.07.002</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.biotno.2025.07.002</RefLink>
      </Reference>
      <Reference refNo="25">
        <RefAuthor>Thilakavathy P</RefAuthor>
        <RefAuthor>Priyan RM</RefAuthor>
        <RefAuthor>Jagatheeswari PA</RefAuthor>
        <RefAuthor>Charles J</RefAuthor>
        <RefAuthor>Dhanalakshmi V</RefAuthor>
        <RefAuthor>Lallitha S</RefAuthor>
        <RefAuthor>Rajendran T</RefAuthor>
        <RefAuthor>Divya B</RefAuthor>
        <RefTitle>Evaluation of Ica Gene in Comparison with Phenotypic Methods for Detection of Biofilm Production by Coagulase Negative Staphylococci in a Tertiary Care Hospital</RefTitle>
        <RefYear>2015</RefYear>
        <RefJournal>J Clin Diagn Res</RefJournal>
        <RefPage>DC16-9</RefPage>
        <RefTotal>Thilakavathy P, Priyan RM, Jagatheeswari PA, Charles J, Dhanalakshmi V, Lallitha S, Rajendran T, Divya B. Evaluation of Ica Gene in Comparison with Phenotypic Methods for Detection of Biofilm Production by Coagulase Negative Staphylococci in a Tertiary Care Hospital. J Clin Diagn Res. 2015 Aug;9(8):DC16-9. DOI: 10.7860&#47;JCDR&#47;2015&#47;11725.6371</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.7860&#47;JCDR&#47;2015&#47;11725.6371</RefLink>
      </Reference>
      <Reference refNo="26">
        <RefAuthor>Tyner H</RefAuthor>
        <RefAuthor>Patel R</RefAuthor>
        <RefTitle>Propionibacterium acnes biofilm - A sanctuary for Staphylococcus aureus&#63; Anaerobe</RefTitle>
        <RefYear>2016</RefYear>
        <RefTotal>Tyner H, Patel R. Propionibacterium acnes biofilm - A sanctuary for Staphylococcus aureus&#63; Anaerobe. 2016 Aug;40:63-7. DOI: 10.1016&#47;j.anaerobe.2016.05.014</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1016&#47;j.anaerobe.2016.05.014</RefLink>
      </Reference>
      <Reference refNo="27">
        <RefAuthor>Manandhar S</RefAuthor>
        <RefAuthor>Singh A</RefAuthor>
        <RefAuthor>Varma A</RefAuthor>
        <RefAuthor>Pandey S</RefAuthor>
        <RefAuthor>Shrivastava N</RefAuthor>
        <RefTitle>Biofilm Producing Clinical Isolates Augmented Prevalence of Antibiotic Resistant Cases in Tertiary Care Hospitals of Nepal</RefTitle>
        <RefYear>2018</RefYear>
        <RefJournal>Front Microbiol</RefJournal>
        <RefPage>2749</RefPage>
        <RefTotal>Manandhar S, Singh A, Varma A, Pandey S, Shrivastava N. Biofilm Producing Clinical Isolates Augmented Prevalence of Antibiotic Resistant Cases in Tertiary Care Hospitals of Nepal. Front Microbiol. 2018;9:2749. DOI: 10.3389&#47;fmicb.2018.02749</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fmicb.2018.02749</RefLink>
      </Reference>
      <Reference refNo="28">
        <RefAuthor>Rezania N</RefAuthor>
        <RefAuthor>Rahmati P</RefAuthor>
        <RefAuthor>Noorbakhsh F</RefAuthor>
        <RefAuthor>Farhadyar N</RefAuthor>
        <RefAuthor>Lotfali E</RefAuthor>
        <RefTitle>Investigation the effects of silver nanoparticles and gold nanoparticles on expression of and genes in biofilm formation of</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Iran J Microbiol</RefJournal>
        <RefPage>510-517</RefPage>
        <RefTotal>Rezania N, Rahmati P, Noorbakhsh F, Farhadyar N, Lotfali E. Investigation the effects of silver nanoparticles and gold nanoparticles on expression of and genes in biofilm formation of. Iran J Microbiol. 2022 Aug;14(4):510-517. DOI: 10.18502&#47;ijm.v14i4.10237</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.18502&#47;ijm.v14i4.10237</RefLink>
      </Reference>
      <Reference refNo="29">
        <RefAuthor>Hamida RS</RefAuthor>
        <RefAuthor>Ali MA</RefAuthor>
        <RefAuthor>Goda DA</RefAuthor>
        <RefAuthor>Khalil MI</RefAuthor>
        <RefAuthor>Al-Zaban MI</RefAuthor>
        <RefTitle>Novel Biogenic Silver Nanoparticle-Induced Reactive Oxygen Species Inhibit the Biofilm Formation and Virulence Activities of Methicillin-Resistant (MRSA) Strain</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Front Bioeng Biotechnol</RefJournal>
        <RefPage>433</RefPage>
        <RefTotal>Hamida RS, Ali MA, Goda DA, Khalil MI, Al-Zaban MI. Novel Biogenic Silver Nanoparticle-Induced Reactive Oxygen Species Inhibit the Biofilm Formation and Virulence Activities of Methicillin-Resistant (MRSA) Strain. Front Bioeng Biotechnol. 2020;8:433. DOI: 10.3389&#47;fbioe.2020.00433</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fbioe.2020.00433</RefLink>
      </Reference>
      <Reference refNo="30">
        <RefAuthor>Heine N</RefAuthor>
        <RefAuthor>Doll-Nikutta K</RefAuthor>
        <RefAuthor>Stein F</RefAuthor>
        <RefAuthor>Jakobi J</RefAuthor>
        <RefAuthor>Ingendoh-Tsakmakidis A</RefAuthor>
        <RefAuthor>Rehbock C</RefAuthor>
        <RefAuthor>Winkel A</RefAuthor>
        <RefAuthor>Barcikowski S</RefAuthor>
        <RefAuthor>Stiesch M</RefAuthor>
        <RefTitle>Anti-biofilm properties of laser-synthesized, ultrapure silver-gold-alloy nanoparticles against Staphylococcus aureus</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Sci Rep</RefJournal>
        <RefPage>3405</RefPage>
        <RefTotal>Heine N, Doll-Nikutta K, Stein F, Jakobi J, Ingendoh-Tsakmakidis A, Rehbock C, Winkel A, Barcikowski S, Stiesch M. Anti-biofilm properties of laser-synthesized, ultrapure silver-gold-alloy nanoparticles against Staphylococcus aureus. Sci Rep. 2024 Feb;14(1):3405. DOI: 10.1038&#47;s41598-024-53782-x</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1038&#47;s41598-024-53782-x</RefLink>
      </Reference>
      <Reference refNo="31">
        <RefAuthor>Fareid MA</RefAuthor>
        <RefAuthor>El-Sherbiny GM</RefAuthor>
        <RefAuthor>Askar AA</RefAuthor>
        <RefAuthor>Abdelaziz AM</RefAuthor>
        <RefAuthor>Hegazy AM</RefAuthor>
        <RefAuthor>Ab Aziz R</RefAuthor>
        <RefAuthor>Hamada FA</RefAuthor>
        <RefTitle>Impeding Biofilm-Forming Mediated Methicillin-Resistant and Virulence Genes Using a Biosynthesized Silver Nanoparticles-Antibiotic Combination</RefTitle>
        <RefYear>2025</RefYear>
        <RefJournal>Biomolecules</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Fareid MA, El-Sherbiny GM, Askar AA, Abdelaziz AM, Hegazy AM, Ab Aziz R, Hamada FA. Impeding Biofilm-Forming Mediated Methicillin-Resistant and Virulence Genes Using a Biosynthesized Silver Nanoparticles-Antibiotic Combination. Biomolecules. 2025 Feb;15(2):. DOI: 10.3390&#47;biom15020266</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;biom15020266</RefLink>
      </Reference>
      <Reference refNo="32">
        <RefAuthor>Mohanta YK</RefAuthor>
        <RefAuthor>Biswas K</RefAuthor>
        <RefAuthor>Jena SK</RefAuthor>
        <RefAuthor>Hashem A</RefAuthor>
        <RefAuthor>Abd Allah EF</RefAuthor>
        <RefAuthor>Mohanta TK</RefAuthor>
        <RefTitle>Anti-biofilm and Antibacterial Activities of Silver Nanoparticles Synthesized by the Reducing Activity of Phytoconstituents Present in the Indian Medicinal Plants</RefTitle>
        <RefYear>2020</RefYear>
        <RefJournal>Front Microbiol</RefJournal>
        <RefPage>1143</RefPage>
        <RefTotal>Mohanta YK, Biswas K, Jena SK, Hashem A, Abd Allah EF, Mohanta TK. Anti-biofilm and Antibacterial Activities of Silver Nanoparticles Synthesized by the Reducing Activity of Phytoconstituents Present in the Indian Medicinal Plants. Front Microbiol. 2020;11:1143. DOI: 10.3389&#47;fmicb.2020.01143</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3389&#47;fmicb.2020.01143</RefLink>
      </Reference>
      <Reference refNo="33">
        <RefAuthor>Pal S</RefAuthor>
        <RefAuthor>Tak YK</RefAuthor>
        <RefAuthor>Song JM</RefAuthor>
        <RefTitle>Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle&#63; A study of the Gram-negative bacterium Escherichia coli</RefTitle>
        <RefYear>2007</RefYear>
        <RefJournal>Appl Environ Microbiol</RefJournal>
        <RefPage>1712-20</RefPage>
        <RefTotal>Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle&#63; A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol. 2007 Mar;73(6):1712-20. DOI: 10.1128&#47;AEM.02218-06</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1128&#47;AEM.02218-06</RefLink>
      </Reference>
      <Reference refNo="34">
        <RefAuthor>Grygiel I</RefAuthor>
        <RefAuthor>Bajrak O</RefAuthor>
        <RefAuthor>W&#243;jcicki M</RefAuthor>
        <RefAuthor>Krusiec K</RefAuthor>
        <RefAuthor>Jo&#324;czyk-Matysiak E</RefAuthor>
        <RefAuthor>G&#243;rski A</RefAuthor>
        <RefAuthor>Majewska J</RefAuthor>
        <RefAuthor>Letkiewicz S</RefAuthor>
        <RefTitle>Comprehensive Approaches to Combatting Biofilms: From Biofilm Structure to Phage-Based Therapies</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Antibiotics (Basel)</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Grygiel I, Bajrak O, W&#243;jcicki M, Krusiec K, Jo&#324;czyk-Matysiak E, G&#243;rski A, Majewska J, Letkiewicz S. Comprehensive Approaches to Combatting Biofilms: From Biofilm Structure to Phage-Based Therapies. Antibiotics (Basel). 2024 Nov;13(11):. DOI: 10.3390&#47;antibiotics13111064</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;antibiotics13111064</RefLink>
      </Reference>
      <Reference refNo="35">
        <RefAuthor>Lin F</RefAuthor>
        <RefAuthor>Wang Z</RefAuthor>
        <RefAuthor>Wu FG</RefAuthor>
        <RefTitle>Carbon Dots for Killing Microorganisms: An Update since 2019</RefTitle>
        <RefYear>2022</RefYear>
        <RefJournal>Pharmaceuticals (Basel)</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Lin F, Wang Z, Wu FG. Carbon Dots for Killing Microorganisms: An Update since 2019. Pharmaceuticals (Basel). 2022 Oct;15(10):. DOI: 10.3390&#47;ph15101236</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.3390&#47;ph15101236</RefLink>
      </Reference>
      <Reference refNo="36">
        <RefAuthor>He L</RefAuthor>
        <RefAuthor>Li Z</RefAuthor>
        <RefAuthor>Gu M</RefAuthor>
        <RefAuthor>Li Y</RefAuthor>
        <RefAuthor>Yi C</RefAuthor>
        <RefAuthor>Jiang M</RefAuthor>
        <RefAuthor>Yu X</RefAuthor>
        <RefAuthor>Xu L</RefAuthor>
        <RefTitle>Intelligent Carbon Dots with Switchable Photo-Activated Oxidase-Mimicking Activity and pH Responsive Antioxidant Activity Adaptive to the Wound Microenvironment for Selective Antibacterial Therapy</RefTitle>
        <RefYear>2024</RefYear>
        <RefJournal>Adv Sci (Weinh)</RefJournal>
        <RefPage>e2406681</RefPage>
        <RefTotal>He L, Li Z, Gu M, Li Y, Yi C, Jiang M, Yu X, Xu L. Intelligent Carbon Dots with Switchable Photo-Activated Oxidase-Mimicking Activity and pH Responsive Antioxidant Activity Adaptive to the Wound Microenvironment for Selective Antibacterial Therapy. Adv Sci (Weinh). 2024 Oct;11(40):e2406681. DOI: 10.1002&#47;advs.202406681</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1002&#47;advs.202406681</RefLink>
      </Reference>
      <Reference refNo="23">
        <RefAuthor>Nabipour YS</RefAuthor>
        <RefAuthor>Hesampour A</RefAuthor>
        <RefAuthor>Ahmady Asbchin S</RefAuthor>
        <RefAuthor>Tajabadi M</RefAuthor>
        <RefAuthor>Rostamzad A</RefAuthor>
        <RefTitle>Comparative study of the effects of biologically synthesized copper and zinc oxide quantum nanodots on biofilm-forming genes in Klebsiella pneumoniae and Staphylococcus aureus bacteria</RefTitle>
        <RefYear>2026</RefYear>
        <RefJournal>Med Sci J Islamic Azad Univ</RefJournal>
        <RefPage>189-99</RefPage>
        <RefTotal>Nabipour YS, Hesampour A, Ahmady Asbchin S, Tajabadi M, Rostamzad A. Comparative study of the effects of biologically synthesized copper and zinc oxide quantum nanodots on biofilm-forming genes in Klebsiella pneumoniae and Staphylococcus aureus bacteria. Med Sci J Islamic Azad Univ. 2026; 36 (2) :189-99. DOI: 10.66224&#47;iau.36.2.189</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.66224&#47;iau.36.2.189</RefLink>
      </Reference>
      <Reference refNo="37">
        <RefAuthor>Nabipour YS</RefAuthor>
        <RefAuthor>Hesampour A</RefAuthor>
        <RefAuthor>Asbchin SA</RefAuthor>
        <RefAuthor>Tajabadi M</RefAuthor>
        <RefAuthor>Rostamzad A</RefAuthor>
        <RefTitle>Green-synthesized quantum dots from quercus brantii for infected polymicrobial wound healing: mechanisms and biocompatibility</RefTitle>
        <RefYear>2026</RefYear>
        <RefJournal>BMC Biotechnol</RefJournal>
        <RefPage></RefPage>
        <RefTotal>Nabipour YS, Hesampour A, Asbchin SA, Tajabadi M, Rostamzad A. Green-synthesized quantum dots from quercus brantii for infected polymicrobial wound healing: mechanisms and biocompatibility. BMC Biotechnol. 2026 Jun;:. DOI: 10.1186&#47;s12896-026-01183-5</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.1186&#47;s12896-026-01183-5</RefLink>
      </Reference>
      <Reference refNo="38">
        <RefAuthor>Swebocki T</RefAuthor>
        <RefAuthor>Barras A</RefAuthor>
        <RefAuthor>Kocot A</RefAuthor>
        <RefAuthor>P&#322;otka M</RefAuthor>
        <RefAuthor>Boukhterroub R</RefAuthor>
        <RefTitle>Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays using broth microdilution method</RefTitle>
        <RefYear>2023</RefYear>
        <RefJournal>protocols</RefJournal>
        <RefPage>1-12</RefPage>
        <RefTotal>Swebocki T, Barras A, Kocot A, P&#322;otka M, Boukhterroub R. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays using broth microdilution method. protocols.io. 2023 Jun 23: 1-12. DOI: 10.17504&#47;protocols.io.5qpvo3x6dv4o&#47;v1</RefTotal>
        <RefLink>https:&#47;&#47;doi.org&#47;10.17504&#47;protocols.io.5qpvo3x6dv4o&#47;v1</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <Table format="png">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Table 1: Sequences of oligonucleotide primers used for quantitative real-time PCR (qRT-PCR) analysis</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <Caption><Pgraph><Mark1>Table 2: Biofilm production ability of </Mark1><Mark1><Mark2>S. aureus</Mark2></Mark1><Mark1> isolates from different clinical samples</Mark1></Pgraph></Caption>
        </Table>
        <Table format="png">
          <MediaNo>3</MediaNo>
          <MediaID>3</MediaID>
        </Table>
        <NoOfTables>3</NoOfTables>
      </Tables>
      <Figures>
        <Figure width="519" height="307" format="png">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption><Pgraph><Mark1>Figure 1: Schematic representation of the green synthesis process of silver (Ag-QDs) and copper (Cu-QDs) quantum dots using oak fruit extract. The extract acts as both reducing and stabilizing agent, leading to nanoparticle formation confirmed by color change and subsequent characterization.</Mark1></Pgraph></Caption>
        </Figure>
        <Figure width="654" height="432" format="png">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <Caption><Pgraph><Mark1>Figure 2: UV&#8211;Vis absorption spectra of silver (Ag-QDs) and copper (Cu-QDs), showing distinct characteristic peaks around 400 nm, confirming the successful synthesis of the quantum dots.</Mark1></Pgraph></Caption>
        </Figure>
        <Figure width="527" height="245" format="png">
          <MediaNo>3</MediaNo>
          <MediaID>3</MediaID>
          <Caption><Pgraph><Mark1>Figure 3: TEM micrograph showing spherical morphology and nanoscale distribution of synthesized quantum dots (representative image).</Mark1></Pgraph></Caption>
        </Figure>
        <Figure width="751" height="561" format="png">
          <MediaNo>4</MediaNo>
          <MediaID>4</MediaID>
          <Caption><Pgraph><Mark1>Figure 4: Relative expression of biofilm-related genes (</Mark1><Mark1><Mark2>icaA, icaD, icaR</Mark2></Mark1><Mark1> in </Mark1><Mark1><Mark2>Staphylococcus aureus</Mark2></Mark1><Mark1>; </Mark1><Mark1><Mark2>bap</Mark2></Mark1><Mark1> and </Mark1><Mark1><Mark2>ompA</Mark2></Mark1><Mark1> in </Mark1><Mark1><Mark2>Acinetobacter baumannii</Mark2></Mark1><Mark1>) following treatment with sub-MIC concentrations of silver quantum dots (Ag-QDs) and copper quantum dots (Cu-QDs). Expression levels were normalized to </Mark1><Mark1><Mark2>16S rRNA</Mark2></Mark1><Mark1> and calculated using the 2&#94;&#8211;</Mark1>&#8710;&#8710;<Mark1>Ct method. Both Ag-QDs and Cu-QDs significantly downregulated gene expression compared with untreated controls, with Ag-QDs exhibiting a stronger inhibitory effect (p&#60;0.05)</Mark1></Pgraph></Caption>
        </Figure>
        <NoOfPictures>4</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>